Login
From:
Fragile X News Today
(Uncensored)
subscribe
Shionogi Acquires Tetra Therapeutics, Rights to Fragile X Treatment
https://fragilexnewstoday.com/news/shionogi-acquires-tetra-therapeutics-rights-bpn14770-fragile-x-treatment/
links
backlinks
Tagged with:
acquisition
alzheimer
bpn14770
pde4d
tetra therapeutics
global rights
shionogi
Shionogi has acquired Tetra Therapeutics, the developer of the BPN14770 treatment candidate for fragile X syndrome and Alzheimer’s disease.
Roast topics
Find topics
Find it!
